Clinical Trial: This Trial Aims to Evaluate the Effect of Two HIV Stigma Reduction Interventions at the Health Facility Level and the Individual Level for People Struggling to Access and Remain in Care in Uganda.

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07708519) titled 'This Trial Aims to Evaluate the Effect of Two HIV Stigma Reduction Interventions at the Health Facility Level and the Individual Level for People Struggling to Access and Remain in Care in Uganda.' on July 13.

Brief Summary: The overall goal of the Ssinga Nze study ("Ssinga Nze" means "If it were me" in Luganda, the local language) is to reduce HIV-related stigma and improve access to HIV care, including antiretroviral treatment (ART) and HIV pre-exposure prophylaxis (PrEP), as well as increase linkage to care among people affected by HIV in Uganda.

The HIV pandemic has a disproportionate impact on populations at risk of HIV, or li...